The murine cytomegalovirus (MCMV) monoclonal antibody 5C7:6 was used in Western analysis to probe MCMV infected murine embryo cells (MEC). This antibody recognizes three virus specific polypeptides of 130, 105, and 95 kDa and pulse-chase experiments demonstrated that these three proteins, although antigenically related, are distinct. The 105-and 95-kDa species were expressed with early kinetics, whereas the 130-kDa protein was synthesized as a true late. By screening a gt11 MCMV cDNA library, the gene encoding these proteins was identified as the M25 open reading frame previously reported by Dallas et al. (Dallas, P. B., Lyons, P. A., Hudson, J. B., Scalzo, A. A., and Shellam, G. R., 1994, Virology 200, 643-650). Immunofluorescent studies monitored the location of pM25, present in the nucleus at 15 h after infection, condensing around the periphery of the nucleus at 18 h, before finally accumulating in the cytoplasm. Immunoelectron microscopy detected gold particles associated with the viral tegument of enveloped virions located in the cytoplasm and extracellular space but not with naked nucleocapsids. Western analysis of MCMV purified virions depicted the presence of the 130-kDa protein, the predominant M25 species, in mature virus particles. Together these findings provide compelling evidence that the 130-kDa M25 polypeptide is a component of the viral tegument.
INTRODUCTION
Located between the nucleocapsid and outer envelope of all herpesviruses is an asymmetric region called the tegument. In human cytomegalovirus (HCMV), the protein composition of the tegument is ill defined but is estimated to be composed of 20-25 proteins, many of them modified by phosphorylation (reviewed Mocarski, 1993; Spaete et al., 1994) . These proteins are derived from both viral and cellular origins and may play a critical role in the regulation of viral gene expression as well as viral maturation and egress (Gibson, 1983; Liu and Stinski, 1992; Baldick and Shenk, 1996; Meyer et al., 1997) .
The most extensively studied HCMV tegument proteins include the gene products of the UL32 (pp150 or major basic phosphoprotein), UL82 (pp71 or upper matrix protein), and UL83 (pp65 or lower matrix protein) open reading frames (ORFs). ppUL32 comprises 20% of the total virion mass (Gibson, 1983) and may play a role in the transport of DNA-filled capsids through the nuclear envelope or stabilization of nucleocapsids in the cytoplasm (Meyer et al., 1997) . ppUL82 functions as a transactivator, enhancing transcription from promoters containing ATF and AP-1 binding sites (Liu and Stinski, 1992) . Included as a ppUL82 target is the HCMV major immediate early (MIE) promoter, and regulation of MIE gene expression is thought to be a central point in controlling both lytic and latent infection. In addition to its role as a transactivator, ppUL82 also enhances viral replication and viral spread (Baldick et al., 1997) . The rapid transport of ppUL83 to the nucleus in the absence of viral gene expression suggests a role for this protein in the initiation of viral infection (Yamauchi et al., 1985; Geballe et al., 1986; Britt and Vugler, 1987; Grefte et al., 1992) . However, although ppUL83 exhibits protein kinase activity (Somogyi et al., 1990) , it is not essential for virus growth in vitro (Schmolke et al., 1995) .
Murine cytomegalovirus (MCMV) has proven a useful model system for investigating HCMV pathogenesis. The apparent MCMV homologues of the HCMV UL82 and UL83 proteins have been described (Cranmer et al., 1996) , and other potential MCMV tegument proteins have been tentatively identified by DNA sequence homology . In an effort to identify and further characterize MCMV proteins located within the tegument, we have examined the kinetic expression of the M25 open reading frame (ORF), first described by Dallas et al. (1994) . Western analysis demonstrates that this gene encodes at least three distinct, yet antigenically related, polypeptides that are expressed with different temporal kinetics. All three proteins are present in both the nucleus and cytoplasm of infected cells in different relative abundance. Western analysis of purified virions and immuno-electron microscopy (EM) studies provide the first direct evidence that the 130-kDa M25 protein is indeed a component of the viral tegument.
RESULTS

Characterization of the 5C7:6 monoclonal antibody
A series of monoclonal antibodies were generated against MCMV and screened for their ability to neutralize the virus in an assay developed by Gonczol et al. (1986) . As shown in Table 1 , sera obtained from a MCMV immune mouse and monoclonal antibodies specific for MCMV glycoprotein H (IE8 and 4B6) were capable of virus neutralization. A modest reduction in viral titer was consistently noted for normal mouse serum in this assay. In contrast, monoclonal antibody 5C7:6, as well as monoclonal antibodies 25G11 and 16F7, which are specific for the MCMV DNA polymerase accessory protein and MCMV glycoprotein B, respectively, exhibited no neutralizing activity. In addition, injection of mice with 5C7:6 antibody did not afford protection upon challenge with a sublethal dose of virus (data not shown).
Identification of MCMV cDNA clones that react with the 5C7:6 antibody To identify the gene encoding the protein recognized by the 5C7:6 monoclonal antibody, a gt11 MCMV cDNA expression library was constructed. Upon screening, several immunoreactive clones were recognized, and plasmid pCH5C7b, which contained the largest insert, was chosen for use in the mapping studies. An EcoRI MCMV cosmid library was examined, and pCH5C7b hybridized exclusively with EcoRI fragment C (Fig. 1) . This finding was confirmed by Southern analysis of MCMV genomic DNA digested with EcoRI or HindIII. Subsequent restriction endonuclease mapping studies identified a 2.2-kb Tth111 I fragment. Determination of its DNA sequence revealed that this fragment contains 1.7 kb of the carboxyl-terminus of the M25 ORF reported by Dallas et al. (1994) as well the carboxyl-terminus of the m25.1 ORF positioned on the complementary DNA strand . To verify which ORF reacted with the 5C7:6 antibody, the DNA sequence of the pCH5C7b probe was determined. This sequence corresponded with the M25 gene, beginning at map position 28,958 in the middle of the ORF and ending at position 28,948, 10 bases downstream from the polyadenylation signal.
Expression of the M25 ORF
To investigate the kinetics of M25 gene expression, MCMV-infected MEC cultures were harvested at 3-h intervals over a 24-h period and processed for Western analysis using the monoclonal antibody 5C7:6 as a probe. Cell cultures were treated with trypsin immediately after infection to remove residual inoculum and permit examination of de novo protein synthesis. As shown in Fig. 2 , the appearance of a virus specific protein was first observed at 9 h after infection (lane 4). The size of this protein, 105 kDa, is in agreement with the predicted size of a protein encoded by the M25 ORF, 103.2 kDa. At 15 h after infection, two other proteins of 130 and 95 kDa were observed (Fig. 2, lane 6) . The 130-kDa polypeptide became the predominate species as infection continued (Fig. 2, lane 9) . As a negative control, Western blots of MCMV-infected MEC cultures were probed with an isotype-matched, irrelevant monoclonal antibody and no signal was detected.
The kinetics of expression of the 105-and 130-kDa polypeptides was consistent with the hypothesis that these proteins might exist in a precursor-product relationship. Furthermore the appearance of the 95-kDa protein coincided with the synthesis of the 130-kDa species, raising the possibility that this protein could be a cleavage or proteolytic degradation product. To address these issues, pulse-chase experiments were performed using the 5C7:6 monoclonal antibody to precipitate the proteins of interest. Based on the results of the Western analysis in Fig. 2 , two time points were chosen for examination, 9 h when only the 105-kDa species was evident and 16 h when all three proteins were observed. As shown in Fig.  3 , immunoprecipitation of proteins isolated from MCMVinfected MEC labeled at 9 h after infection indicated the presence of both the 105-and 95-kDa polypeptides (lane 2). This result differs from the data obtained by Western analysis (Fig. 2, lane 4) . Upon a chase to 20 h after infection in the presence of excess cold methionine, no change in the protein profile was noted (lane 3). Immunoprecipitation of proteins from MCMV-infected MEC labeled at 16 h demonstrated the presence of the 130-, 105-, and 95-kDa polypeptides (lane 5). The relative ratio of these three proteins remained constant upon a chase to 20 h after infection (lane 6). In addition, a minor, faster migrating band of ϳ70 kDa was also apparent upon chase (lane 6, denoted by an asterisk) and most probably represents a degradation product as it was not present in the pulse. These results denote two important points. First, there is no evidence of a precursor-product relationship between the 105-and 130-kDa proteins. Second, because the 95-kDa species was synthesized before the 130-kDa polypeptide and its abundance does not increase over time, it can not be a degradation product. These findings suggest that expression from the M25 ORF results in the synthesis of multiple protein products.
The M25 ORF appears to encode the 130-, 105-, and 95-kDa polypeptides To address the possibility that all three polypeptides recognized by the 5C7:6 monoclonal antibody are encoded by the M25 ORF, the following experiment was performed. Transient expression of pMC302, an expression vector containing the entire M25 ORF, was examined in Vero cells. As shown in Fig. 4 , expression of this plasmid resulted in the generation of four novel proteins (lane 2) not present in cells transfected with vector alone (lane 1). Based on electrophoretic mobility, the apparent molecular weights of the three largest polypeptides were 135, 105, and 94 kDa, similar to the results obtained with MCMV-infected MEC. Furthermore, the relative abundance of these three proteins was similar to the pattern of pM25 expression observed in infected cells. A fourth protein, 53 kDa in size, may represent a unique protein not previously observed in MCMV-infected MEC cultures or a proteolytic degradation product. This data support the idea that the M25 ORF encodes three antigenically related protein products.
Classification of M25 proteins based on kinetic expression
To monitor the synthesis of the M25 proteins with respect to the replicative cycle of MCMV, Western analysis using the 5C7:6 monoclonal antibody was performed on MCMV-infected cell lysates exposed to various metabolic inhibitors ( 
Localization of pM25 within the infected cell
To determine the intracellular location of pM25, protein expression was monitored by indirect immunofluorescence using the 5C7:6 monoclonal antibody. Expression of pM25 was first observed 12 h after infection and at this early stage, between 12 and 15 h, the nucleus of infected MEC exhibited a strong punctate pattern (Fig. 6A ). Minimal staining of the cytoplasm was observed. At 18 h after infection, the M25 proteins were condensed around the periphery of the nucleus (Fig. 6B) . By 24 h after infection, the staining pattern for pM25 again changed dramatically. Immunofluorescence appeared to be predominately cytoplasmic in nature, with the majority of pM25 concentrated in aggregates (Fig. 6C ). Little nuclear staining was observed. In all three panels, the specificity of the primary and secondary antibodies was evident by the absence of reactivity of uninfected MEC within the monolayer. In addition, no staining was noted with an isotype matched, irrelevant monoclonal antibody (Fig. 6D ).
The 5C7:6 antibody recognizes three distinct polypeptides of 130, 105, and 95 kDa (Fig. 3) . To further interpret the results obtained in Fig. 6 , nuclear (nuclear matrix) and cytoplasmic (soluble) fractions were prepared from MCMV-infected MEC. As shown in Fig. 7 , Western analysis of these fractions indicated that all three polypeptides were present in both the nucleus and cytoplasm between 18 and 24 h after infection. However, the 105-kDa protein, first observed in the nucleus at 12 h after FIG. 6 . Intracellular localization of pM25 at different times after MCMV infection. MCMV-infected MEC monolayers were harvested every 3 h after infection over 24-h period and analyzed by indirect immunofluorescence using the 5C7:6 monoclonal antibody (A-C) or an isotype-matched, irrelevant monoclonal antibody (D). Shown here are 15-h (A), 18-h (B), and 24-h (C and D) time points with the phase and immunofluorescent images merged. Magnification, ϫ800.
FIG. 7.
Comparison of nuclear and cytoplasmic fractions of MCMV-infected cells for the presence of M25 polypeptides. MCMV-infected MEC cultures were harvested at the indicated time points and separated into nuclear and cytoplasmic fractions, as described under Methods and Materials. MCMV-encoded proteins were visualized by Western analysis using the monoclonal antibodies 5C7:6, 25G11, and 16F7, which are specific for pM25, the DNA polymerase accessory protein, and glycoprotein B, respectively. infection, was the predominant species in the nucleus until 24 h after infection. In contrast, the 130-kDa protein, first noted at 18 h, was the major species present in the cytoplasm during the late stages of infection. Cytoplasmic fractions, particularly at late times of infection, appeared to be susceptible to proteolytic degradation, even though multiple protease inhibitors were present in the lysis buffer. Western analysis of the nuclear and cytoplasmic fractions was also performed with the monoclonal antibodies 25G11 and 16F7. These two antibodies recognize the MCMV DNA polymerase accessory protein (25G11) and MCMV glycoprotein B (16F7) and serve as markers for nuclear and cytoplasmic purity, respectively. Together, these results suggest that the nuclear staining observed at early times after infection (Fig. 6A) is representative of the 105-kDa protein, whereas the cytoplasmic aggregates present at 21 and 24 h (Fig. 6C ) are composed predominately of the 130-kDa polypeptide.
The 130-kDa M25 protein is present in the tegument
The localization of M25 gene products during MCMV replication was examined in greater detail using immunogold labeling with the 5C7:6 antibody. In the nucleus of MCMV-infected MEC, both translucent and electron dense capsids (also referred to as type A and type B capsids, respectively) were observed (Fig. 8A) . These structures represent various stages of nucleocapsid maturation, but neither reacted with the 5C7:6 antibody. Instead, pM25 was localized in electron dense amorphous material that was not present in uninfected cells. Individual virions and multicapsid structures were present in the cytoplasm (Fig. 8B) . Multicapsid virions contain an average of 2-20 capsids enveloped by a single membrane and are a distinguishing feature of MCMV infection (Hudson et al., 1976) . Immunogold was consistently localized to both single and multicapsid virions, and the staining pattern was associated with the viral tegument, being located externally to the nucleocapsid structure (Fig. 8B) . This was also true for mature virions found extracellularly (Fig. 8C) . Immunogold was occasionally found associated with the Golgi apparatus in the absence of viral structures. Staining was not observed in uninfected MEC or in MCMV-infected MEC samples in the absence of 5C7:6 antibody. Thus we conclude that at least one M25 polypeptide is a component of the MCMV tegument.
To identify which M25 polypeptide(s) was present in the tegument, Western analysis of purified virions was performed (Fig. 9) . As shown in lane 1, the 130-kDa M25 protein was detected in mature MCMV virus particles. However, no compelling evidence for the presence of the 95-or 105-kDa protein was noted. At this time, it is not clear whether the early M25 proteins are absent from the viral tegument or beyond the limits of detection in this assay. In contrast, all three M25 proteins were present in MCMV-infected MEC harvested at the same time (lane 2). Thus it was concluded that the most abundant M25 protein, the 130-kDa species, is a component of the tegument.
DISCUSSION
The components of the viral tegument are uniquely positioned to play a significant role in multiple stages of the viral pathway, including regulation of IE gene expression and particle maturation and egress. The limited information available on the composition of the MCMV tegument is based largely on shared genomic colinearity and DNA sequence homology with HCMV. In the studies described, we have characterized the gene products of the MCMV M25 ORF, demonstrating that this gene encodes three distinct proteins, at least one of which is located within the viral tegument.
The M25 gene first was identified by Dallas et al. (1994) ; however, the monoclonal antibody used in their studies was cross-reactive with host cell proteins, thus restricting their analysis (Farrell and Shellam, 1990 ). Utilizing a different monoclonal reagent of higher specificity, we have shown by immunoelectron microscopy that pM25 is associated with the tegument of multicapsid and single-capsid virions located within the cytoplasm and extracellular space of infected monolayers, but not with naked nucleocapsids (Fig. 8) . Western analysis of purified virions demonstrated that the most abundant M25 protein, the 130-kDa species, was present in virus particles (Fig. 9) , and on the basis of its sensitivity to DNA replication inhibitors, this protein was classified as a true late (Fig. 5) . These findings are in agreement with studies of HCMV pUL25, the homologue of MCMV pM25. Baldick and Shenk (1996) examined the protein composition of purified HCMV virions and, through amino acid sequence analysis, identified the presence of the UL25 gene product in mature particles and dense bodies. Using confocal and immunoelectron microscopy techniques, Zini et al. (1999) have confirmed these earlier findings. Furthermore the expression of the HCMV UL25 ORF was shown to occur with late kinetics .
In addition to the 130-kDa late protein, the M25 ORF encoded two other polypeptides of 105 and 95 kDa that are expressed with early kinetics. Pulse-chase experiments (Fig. 3) confirmed that although all three share a common antigenic site, these proteins are distinct. Multiple promoters differentially regulating a single gene have been described for other herpesviruses (Hall et al., 1982; Draper et al., 1986; Chang et al., 1989) but was not found to be characteristic of HCMV UL25 gene expression. The MCMV M25 ORF is 2796 nucleotides in length, significantly larger than the HCMV UL25 ORF of 1968 nucleotides (Chee et al., 1990; Rawlinson et al., 1996) . FIG. 8 . Ultrastructural localization of pM25 by immuno-electron microscopy. MCMV-infected MEC were harvested at 24 h and labeled with immunogold using the 5C7:6 monoclonal antibody. Representative thin sections depict the nucleus (A), cytoplasm (B), and extracellular space (C). pM25 was associated with patches of amorphous electron dense material in the nucleus but not nucleocapsids (A), as well as with enveloped multicapsid and single-capsid virions present in the cytoplasm (B) and extraceullular space (C). Bar scale ϭ 0.5 m.
BLAST alignment of the predicted proteins encoded by these two genes shows 26% identity at the amino acid level. However, this shared homology is not dispersed throughout the MCMV M25 protein but restricted to the carboxyl-terminus from amino acids 494 to 880. This suggests that functional differences may exist between the gene products of the HCMV UL25 and MCMV M25 ORFs.
Northern analysis performed by Dallas et al. (1994) identified a single 3-kb M25 transcript expressed late in infection. S1 nuclease studies mapped the position of the 5Ј end of this mRNA to lie ϳ20 bp upstream of a strong consensus TATA box positioned 148 nucleotides within the M25 ORF (Dallas et al., 1994) . Located downstream of the predicted start site of translation is a potential downstream activation sequence (DAS). This signal, ACCG(T/A)C, is repeated three times within the first 50 nucleotides of the predicted translated region, although it is the position, not the actual sequence, that is thought to be critical for function. Direct evidence supporting the importance of these signals in M25 late gene expression is lacking, but similar elements are characteristic of HSV-1 late promoters (Wagner et al., 1995) . Based on this information, we hypothesize that the M25 late promoter lies within the M25 ORF and is responsible for regulating the synthesis of the 3-kb late mRNA and the 130-kDa M25 protein.
In an attempt to identify potential early promoters, the DNA sequence 600 nucleotides upstream from the start of the M25 ORF was examined for the presence of TATA boxes and binding sites of known eukaryotic transcriptional factors (ATF, NF-75 B, AP-1, SRE, and SP-1 sites). No significant TATA box motifs were found; however, multiple potential SP-1 sites were located from Ϫ7 to Ϫ250. SP-1 appears to be critical for the activation of the HCMV UL54 (DNA polymerase) early promoter (Kerry et al., 1996) , and SP-1 has been shown to drive transcription from TATA-less promoters (Swick et al., 1989; Blake et al., 1990) . Preliminary RT-PCR experiments have detected a M25 mRNA that hybridizes with the start of the M25 ORF and the transcription of which appears to be regulated by an early promoter (Wu, unpublished results). The ability of Dallas et al. (1994) to detect only a single late transcript from total RNA suggests that the M25 early mRNAs may be present in low abundance. To overcome this problem, studies are currently underway to examine M25 gene expression by isolating mRNA from MCMV-infected cells.
Much controversy still surrounds the pathway of envelopment and egress of herpesvirus particles, including the precise cellular location of tegument assembly. A recent report by Sanchez et al. (1998) characterized a direct interaction between the HCMV tegument protein UL83 and the lamin proteins of the nuclear matrix. In this study, ppUL83 was compartmentalized in the nucleus, accumulating along the periphery. Ward et al. (1996) described the aggregation of capsid proteins surrounding the periphery of the nucleus in herpes simplex virusinfected cells. These structures, termed assemblons, are hypothesized to be involved in capsid assembly and have been shown to contain tegument proteins. Our immunofluorescent studies (Fig. 6 ) have depicted the presence of M25 proteins in the nucleus during early stages of infection, followed by aggregating around the nucleus, and finally accumulating in the cytoplasm during the late phase of infection. All three M25 proteins are present in both the nucleus and cytoplasm of infected cells, albeit in different relative abundance. In contrast, HCMV UL25 expression was restricted solely to the cytoplasm . Immunofluorescent examination of HCMV tegument proteins UL82 and UL83 revealed a staining pattern that mimics MCMV pM25, being present in the nucleus at early times after infection, but changing dramatically with time. By 48 h after infection, the nuclear staining diminished and cytoplasmic immunofluorescence appeared to be condensed into "cap-like" structures (Hensel et al., 1995 (Hensel et al., , 1996 . A similar concentration of cytoplasmic staining also was reported for HCMV tegument protein UL32 (Hensel et al., 1995) . It is tempting to speculate that this consolidation of tegument proteins around the nucleus and in the cytoplasm is important for the acquisition of tegument during particle maturation.
On the basis of the predicted amino acid sequence homology, Chee et al. (1990) identified HCMV UL25 as part of a two-member gene family composed of UL25 and UL35. A similar family is encoded by MCMV , making these proteins unique to betaherpesviruses. Interestingly, human herpesvirus-6 and human herpesvirus-7, two recently discovered betaherpesviruses, encode either a homologue of HCMV UL25 or UL35, but not both (Gompels et al., 1995 ; Nich- olas, 1996; Stefan et al., 1997) . The biological function of this gene family is unknown and the results presented here represent an important first step in unraveling this puzzle.
METHODS AND MATERIALS
Cells and virus
Mouse embryo cells (MEC) were prepared from embryos of late-term pregnant CD-1 mice by trypsin-EDTA disaggregation and maintained in tissue culture using Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS; Gemini Bio-Products), 100 units/ml penicillin, and 50 g/ml streptomycin. The K181 strain of MCMV was propagated as previously described (Shanley et al., 1993) .
Production of monoclonal hybridomas
A series of monoclonal hybridomas generating antibodies against MCMV were produced by a modification of the method of Togashi et al. (1981) . Briefly, BALB/c mice were infected by intraperitoneal injection with 1 ϫ 10 4 PFU MCMV, followed by additional virus challenges of 1 ϫ 10 5 PFU at 2 and 3 months. After a 6-to 8-week rest period, the mice received a suspension of 1 ϫ 10 6 MCMV infected BALB/c fibroblasts. Four to 6 days later, mice were killed, and their serum was collected to determine viral antibody titers. Spleen cells were treated with 0.72% ammonium chloride to remove residual red blood cells and fused to NSO-1-Ag myeloma cells (American Type Culture Collection, ATCC) for hybridoma production using polyethylene glycol 1000. The hybridomas were selected by maintenance in HAT medium [Eagle's minimal essential medium (MEM) supplemented with 15% FCS (Gemini Bio-Products), 100 M hypoxanthine, 16 M thymidine and 0.4 M aminopterin (all purchased from Sigma)].
All hybridomas (5C7:6, IE8, 4B6, 23G11, and 16F7) were evaluated for neutralizing activity using a modification of a microneutralization assay that scores for a reduction in the number of plaques (Gonczol et al., 1986) . Briefly, MCMV strain K181 was diluted to achieve 50 plaques per well on a 48-well plate and incubated with serial dilutions of each monoclonal antibody for 1 h at 37°C. After the addition of guinea-pig complement, incubation was continued for 30 min, and this virus-antibody-complement mixture was added to monolayers of MEC for 1 h. The cells were overlaid with 1% methyl cellulose and incubation continued for 4 days at 37°C before plaques were visualized with methylene blue. Samples were examined in quadruplicate with each antibody being assayed at least twice. MCMV immune mouse serum and normal mouse serum served as positive and negative controls, respectively.
Mapping the 5C7 epitope and DNA sequence analysis Polyadenylated RNA, isolated from MCMV infected MEC using the Micro Fast-Track system (Invitrogen), was used to generate a gt11 cDNA library (Sambrook et al., 1989) . This library was screened with the 5C7:6 monoclonal antibody at a 1:100 dilution and 56 positive plaques were identified. Four of these plaques were further purified and plasmid pCH5C7b, which contained the largest insert (1.9 kb), was used for subsequent mapping studies. An EcoRI library of MCVM strain K181, representing ϳ60% of the total viral genome, (gift of Dr. M. Colin Jordan, Oregon Health Sciences University) was digested with EcoRI, resolved on a 0.8% agarose gel, transferred to GeneScreen Plus (New England NuclearDupont), and hybridized with 32 P-labeled pCH5C7b. Autoradiographic analysis revealed that this probe recognized EcoRI fragment "C." A series of EcoRI fragment C subclones was generated using various restriction endonucleases and examined by Southern analysis. The final subclone, a 2.2-kb Tth111 I fragment, as well as the pCH5C7b insert, were sequenced using an automated DNA sequencer (Perkin-Elmer) by the Molecular Core Facility at the University of Connecticut Health Center.
Western analysis
Approximately 1 ϫ 10 6 MCMV-infected MEC cells were harvested at 3, 6, 9, 12, 15, 18, 21 , and 24 h by scraping in 500 l lysis buffer [50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.1% SDS; 1% Triton-X 100; and 1 mM phenylmethylsulfonyl fluoride (PMSF)]. Proteins were resolved by separation through a 6% SDS-polyacrylamide gel and transferred to PVDF membranes (BioRad). An identical gel was stained with Coomassie brilliant blue to normalize the amount of protein present in each sample. The blots were incubated with 5C7:6 monoclonal antibody (1:100 dilution) and detected with an alkaline phosphatase-conjugated goat anti-mouse antibody (1:3000 dilution; Sigma). Immunocomplexes were visualized using NBT (nitroblue tetrazolium)-BCIP (5-bromo-4-chloro-3-indolylphosphate toluidinium) (both purchased from Sigma) as the substrate. As a negative control, Western blots of MCMV-infected MEC were probed with an isotype-matched (IgG1), irrelevant monoclonal antibody specific for rat K-Cadherin (1:1000 dilution, Transduction Laboratories).
Expression of MCMV early proteins was examined by incubating MCMV-infected cell monolayers in the presence of phosphonoformic acid (PFA; Sigma) at 100 g/ml.
Pulse-chase experiments
Metabolic labeling of proteins from MCMV-infected and -uninfected MEC was accomplished as follows. Cul-tures were "starved" by incubation for 1 h at 37°C in methionine/cysteine free DMEM supplemented with 10% dialyzed FCS. Incubation was continued for 1 h in similar medium containing 300 Ci/ml of 35[S]methionine (Amersham). One T-75 flask was harvested immediately (pulse), and the other flask (chase) was washed three times in medium and incubated in complete DMEM with an excess of 1 mM cold methionine. At 20 h after infection, cell monolayers were washed twice in ice-cold PBS and collected by scraping in 0.75 ml of RIPA buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet-P40, 0.25% deoxycholic acid, 0.2% SDS, aprotinin, leupeptin, pepstatin, and PMSF].
To pre-clear the cellular lysates, 75 l of Protein A Sepharose beads (Sigma) in a 50% slurry were added to each sample for 30 min at 4°C. Immunocomplexes were generated by the addition of 25 l of 5C7:6 monoclonal antibody for 2 h at 4°C, followed by the addition of 30 l of rabbit anti-mouse IgG (Organon Tekinika) for 2 h at 4°C. Complexes were collected by incubation with Protein A Sepharose beads at 4°C for 2 h. After three washes with ice-cold RIPA, the protein precipitates were analyzed by SDS-PAGE.
Construction of pMC302 and transfection assays
A 4.3-kb BamHI-Acc65I (KpnI) fragment was isolated from MCMV EcoRI fragment C and cloned into the corresponding sites of the expression vector, pcDNA3.1(Ϫ) (Invitrogen). This plasmid, pMC302, contains a 19-bp region upstream of the M25 ORF as well as the entire M25 ORF and 583 bp of the carboxyl-terminus of the m25.1 gene on the complementary DNA strand (see Fig.  1 ). Transfections were performed in 35-mm dishes seeded the previous day with 2 ϫ 10 5 Vero cells (ATCC). Plasmid DNA (2 g/dish) was introduced into cells with 5 l of lipofectamine (Gibco/BRL) with vector alone serving as a negative control. After 24 h, cells were harvested in 300 l of RIPA buffer and gene expression was analyzed by Western analysis using the 5C7:6 monoclonal antibody.
Indirect immunofluorescent assays
The intracellular location of pM25 was examined by indirect immunofluorescence using the 5C7:6 monoclonal antibody. MEC, seeded onto cover slips, were infected with MCMV at a m.o.i. of 1. At various times after infection (i.e., 3, 6, 9, 12, 15, 18, 21 , and 24 h), cells were fixed with 3.75% formaldehyde, permeablized with 0.5% Triton-X 100, and stained with monoclonal 5C7:6 antibody at a 1:100 dilution. After three washes with PBS, the cells were exposed to goat anti-mouse IgG conjugated with rhodamine (Organon Tekinika) for 1 h. After three washes in PBS, the coverslips were mounted in veronal buffered glycerol, pH 8.6 (25 mM 5,5-diethylbarbituric acid, 50 mM NaCl, and 50% glycerol) in preparation for phase-contrast and fluorescence analysis using a Leitz Diaplan microscope. Negative controls included uninfected MEC probed with 5C7:6 monoclonal antibody and MCMV-infected MEC monolayers screened with rat KCadherin monoclonal antibody (an isotype matched, irrelevant reagent).
Preparation of nuclear and cytoplasmic fractions MEC were infected as described above, and two T-75 flasks were harvested for each time point at 12, 15, 18, 21, and 24 h after infection. Monolayers were scraped in PBS with 1% Nonidet-P40 and protease inhibitors and centrifuged to pellet the nuclear matrix. The soluble (cytoplasmic) fraction was removed, and the nuclei were washed repeatedly in PBS before resuspension in RIPA buffer. The protein profiles of these two fractions were compared by Western analysis using the 5C7:6 antibody as a probe. The identity of these fractions was confirmed using monoclonal antibodies specific for the DNA polymerase accessory protein (25G11) and glycoprotein B (16F7), MCMV proteins that are present in the nucleus and cytoplasm, respectively.
Purification of virions
Fourteen T-75 flasks of MEC were infected at a m.o.i. of 5 and harvested after 24 h by scraping in PBS. This time point was selected due to an increase in pM25 degradation noted at later times of infection. Virus particles, released after sonication, were treated with DNaseI (10 g/ml) and collected on a 10% sucrose-TE cushion by centrifugation at 70,000 g for 1.5 h at 15°C. The virion pellet was resuspended in TE with protease inhibitors, layered on a 10 to 50% potassium tartrate gradient, and centrifuged for 155,000 g for 1.5 h at 15°C. The resulting virion band was extracted, dialyzed against TBS (10 mM Tris-HCl, pH 7.5, and 0.9% NaCl) overnight, and concentrated by methanol precipitation with glycogen at 20 g/ml (Boehringer Mannheim) acting as a carrier. The protein composition of the virions was determined by Western analysis as described above.
Electron microscopy
MCMV-infected and -uninfected MEC were harvested at 24 h and fixed for 1 h at room temperature in 3% paraformaldehyde-0.1% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. The monolayers were rinsed and stored briefly at 4°C in 0.1 M cacodylate buffer, pH 7.4, before being embedded in 3% low-gelling agarose. The resulting pellets were trimmed into small pieces, dehydrated in methanol, embedded in Lowicryl K4M resin, and polymerized under ultraviolet light at Ϫ20°C. Thin sections were cut with a diamond knife and collected on Formvar-coated nickel grids. Immunogold labeling was performed as previously described (Hand, 1995) using 5C7:6 monoclonal antibody diluted 1:50 in 1% BSA-5% normal goat serum in PBS. Sections were examined and photographed in a Philips CM10 transmission electron microscope.
